Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenofovir Douche Distribution and PK (DREAM-02)
NCT04195776Phase 1Completed
- Sponsor
- Johns Hopkins University
- Start
- Jun 2021
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of tenofovir in human immunodeficiency virus infection (HIV), sponsored by Johns Hopkins University. Primary endpoint: Change in Tenofovir Diphosphate (TFV-DP) concentration at 6 months. Started Jun 2021; status: completed.
02
Drugs
tenofovir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT04195776.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04195776.